Ligand Pharmaceuticals
LGNDLigand Pharmaceuticals is a biopharmaceutical royalty company that specializes in acquiring and managing diversified royalty streams from high-value medicines.
Earnings
Next report
Nov 5, 2026 (in 2 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Ligand Pharmaceuticals is a biopharmaceutical royalty company that specializes in acquiring and managing diversified royalty streams from high-value medicines. The company deploys capital through royalty purchases, development-stage financing, and strategic acquisitions of assets with embedded royalty rights. Its business model focuses on generating long-duration, non-dilutive cash flows with a lean corporate infrastructure by leveraging the R&D and commercial capabilities of its partners.
Ligand occupies a niche as a high-margin royalty aggregator with significant operating expertise, differentiating itself from traditional biotech firms by avoiding high-cost R&D infrastructure.
FAQ
- What is Ligand Pharmaceuticals's market cap?
- Ligand Pharmaceuticals (LGND) has a market capitalization of $5.5B and trades on NASDAQ.
- What is Ligand Pharmaceuticals's revenue and profitability?
- Ligand Pharmaceuticals generated $290.5M in trailing twelve-month revenue with net income of $197.2M, representing a net margin of 67.9%. Gross margin stands at 91.9%, with free cash flow of $131.4M. The latest reported period is Q2 2026.
- Who are Ligand Pharmaceuticals's competitors?
- Ligand Pharmaceuticals's key competitors include Royalty Pharma, Roivant Sciences Ltd. Common Shares, Rigel Pharmaceuticals Inc. (New), and others. These companies compete in similar markets and product categories.
- Who does Ligand Pharmaceuticals partner with?
- Ligand Pharmaceuticals's notable partners include Amgen, Merck, Travere Therapeutics, and others.
- What subsidiaries does Ligand Pharmaceuticals have?
- Ligand Pharmaceuticals's subsidiaries include CyDex Pharmaceuticals, Ligand UK Development Limited, Pelthos Therapeutics, and others.
- Where is Ligand Pharmaceuticals headquartered?
- Ligand Pharmaceuticals is headquartered in United States of America and employs approximately 58 people. It has been publicly traded since 1994.
